Diabetes Mellitus Type 2
Selective sodium-glucose transporter-2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control with type 2 diabetes mellitus
Initial: 100 mg PO qDay taken before the first meal of the day
May increase dose to 300 mg qDay in patients tolerating 100 mg/day who have an eGFR≥60 mL/min/1.73 m² and require additional glycemic control